Biotech & Longevity: 6 Jul – 12 Jul
No boards ran in this window, so there is no arc to read.
—
pressure at the week’s end, 0–100
—
move across the week
7
editions published
487
sources read behind them
No written analysis for this week
Everything on this page is measured from the week’s own boards and editions. The written read is added when the engine runs its report pass; a week without one still has its record.
The week’s editions · 7
A quiet approval for a slow kidney disease — and an immune system we're learning to calm
Doctors have replaced the dopamine in Parkinson's for 60 years — now they're trying to replace the cells that make it
Three big drug programs died this week — and the one that hurts most did everything it was designed to do
A gentler way to clear the bone marrow — and a KRAS lung-cancer race gets a new front-runner
Big pharma spent billions this week buying biotechs it could have built
The new US health aid comes with strings — and some African governments are saying no
The pills that quietly erased obesity's heart-risk gap — and a UK weight-loss tablet hits the shelves
The same week, another beat